These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37471262)

  • 1. Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
    Melgar M; Britton A; Roper LE; Talbot HK; Long SS; Kotton CN; Havers FP
    MMWR Morb Mortal Wkly Rep; 2023 Jul; 72(29):793-801. PubMed ID: 37471262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus Prefusion F vaccine.
    Falsey AR; Walsh EE
    Cell; 2023 Jul; 186(15):3137-3137.e1. PubMed ID: 37478816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trial.
    Huang LM; Schibler A; Huang YC; Tai A; Chi H; Chieng CH; Wang JL; Goldbart A; Tang SP; Huang YC; George S; Alabaz D; Bentur L; Su SC; de Bruyne J; Karadag B; Gu F; Zou G; Toovey S; DeVincenzo JP; Wu JZ
    Influenza Other Respir Viruses; 2023 Jul; 17(7):e13176. PubMed ID: 37502622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory Syncytial Virus: A Systematic Review and Meta-Analysis of Tomographic Findings (2000-2022).
    Riccò M; Corrado S; Palmieri S; Marchesi F
    Children (Basel); 2023 Jul; 10(7):. PubMed ID: 37508666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why has the epidemiology of RSV changed during the COVID-19 pandemic?
    Abu-Raya B; Viñeta Paramo M; Reicherz F; Lavoie PM
    EClinicalMedicine; 2023 Jul; 61():102089. PubMed ID: 37483545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial.
    Sáez-Llorens X; Norero X; Mussi-Pinhata MM; Luciani K; de la Cueva IS; Díez-Domingo J; Lopez-Medina E; Epalza C; Brzostek J; Szymański H; Boucher FD; Cetin BS; De Leon T; Dinleyici EC; Gabriel MÁM; Ince T; Macias-Parra M; Langley JM; Martinón-Torres F; Rämet M; Kuchar E; Pinto J; Puthanakit T; Baquero-Artigao F; Gattinara GC; Arribas JMM; Ramos Amador JT; Szenborn L; Tapiero B; Anderson EJ; Campbell JD; Faust SN; Nikic V; Zhou Y; Pu W; Friel D; Dieussaert I; Lopez AG; McPhee R; Stoszek SK; Vanhoutte N
    J Infect Dis; 2024 Jan; 229(1):95-107. PubMed ID: 37477875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Live-Attenuated Intranasal Respiratory Syncytial Virus (RSV) Vaccine RSV/6120/ΔNS2/1030s in RSV-Seronegative Young Children.
    Karron RA; Luongo C; Woods S; Oliva J; Collins PL; Buchholz UJ;
    J Infect Dis; 2024 Feb; 229(2):346-354. PubMed ID: 37493269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trajectory of the FDA approval of the first vaccine targeting RSV: A greek tragedy with a happy ending.
    Bellanti JA; Settipane RA
    Allergy Asthma Proc; 2023 Jul; 44(4):217-219. PubMed ID: 37480204
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunization, not vaccination: monoclonal antibodies for infant RSV prevention and the US vaccines for children program.
    Sevilla JP
    J Med Econ; 2023; 26(1):991-997. PubMed ID: 37498791
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Bennett JC; Emanuels A; Heimonen J; O'Hanlon J; Hughes JP; Han PD; Chow EJ; Ogokeh CE; Rolfes MA; Lockwood CM; Pfau B; Uyeki TM; Shendure J; Hoag S; Fay K; Lee J; Sibley TR; Rogers JH; Starita LM; Englund JA; Chu HY
    Front Pediatr; 2023; 11():1198278. PubMed ID: 37484765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of RSV-related hospitalisations in children and adults over a 7 year-period before, during and after the COVID-19 pandemic.
    Kiefer A; Pemmerl S; Kabesch M; Ambrosch A
    J Clin Virol; 2023 Sep; 166():105530. PubMed ID: 37481874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink.
    Katherine Yih W; Daley MF; Duffy J; Fireman B; McClure DL; Nelson JC; Qian L; Smith N; Vazquez-Benitez G; Weintraub E; Williams JTB; Xu S; Maro JC
    Vaccine; 2023 Aug; 41(36):5265-5270. PubMed ID: 37479610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the full health and economic benefits of current and future influenza vaccines.
    Lafond KE; Gharpure R; Dugan VG; Azziz-Baumgartner E
    BMC Med; 2023 Jul; 21(1):273. PubMed ID: 37501176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Year-Round Respiratory Syncytial Virus Transmission in The Netherlands Following the COVID-19 Pandemic: A Prospective Nationwide Observational and Modeling Study.
    Löwensteyn YN; Zheng Z; Rave N; Bannier MAGE; Billard MN; Casalegno JS; Pitzer VE; Wildenbeest JG; Weinberger DM; Bont L;
    J Infect Dis; 2023 Nov; 228(10):1394-1399. PubMed ID: 37477906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the true incidence of seasonal respiratory syncytial virus-confirmed hospitalizations in preterm and term infants in Western Australia.
    Sarna M; Gebremedhin A; Richmond P; Levy A; Glass K; Moore HC
    Vaccine; 2023 Aug; 41(36):5216-5220. PubMed ID: 37474407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Travel-Associated Dengue Cases - United States, 2010-2021.
    Wong JM; Rivera A; Volkman HR; Torres-Velasquez B; Rodriguez DM; Paz-Bailey G; Adams LE
    MMWR Morb Mortal Wkly Rep; 2023 Jul; 72(30):821-826. PubMed ID: 37498793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Care Provider Knowledge Regarding Alpha-gal Syndrome - United States, March-May 2022.
    Carpenter A; Drexler NA; McCormick DW; Thompson JM; Kersh G; Commins SP; Salzer JS
    MMWR Morb Mortal Wkly Rep; 2023 Jul; 72(30):809-814. PubMed ID: 37498792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pseudovirus-Based Entry Assay to Evaluate Neutralizing Activity against Respiratory Syncytial Virus.
    Hu L; Jiang J; Tang Y; Mei L; Wu L; Li L; Chen H; Long F; Xiao J; Peng T
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophils as potential biomarkers in respiratory viral infections.
    Macchia I; La Sorsa V; Urbani F; Moretti S; Antonucci C; Afferni C; Schiavoni G
    Front Immunol; 2023; 14():1170035. PubMed ID: 37483591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Zebra Among the Horses: Clinical Implications of Malaria in the United States.
    Huits R; Wallender E; Angelo KM; Libman M; Hamer DH
    Ann Intern Med; 2023 Sep; 176(9):1269-1270. PubMed ID: 37487212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.